Forward P/S Multiple: Venus Concept (VERO)
Venus Concept Inc. (VERO) generates revenue through the leasing and sale of aesthetic systems for beauty clinics. The forward price-to-sales ratio on the GURU.Markets chart illustrates the current market valuation, where 0.00 describes the current status of the metric. However, high demand cyclicality and debt load issues coupled with low production efficiency limit the growth potential of the business value.
Summary analytical data breakdowns for Venus Concept Inc. (VERO)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Venus Concept Inc.|VERO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital venusconcept.com|VERO - Company Aggregate Debts|Debt to Book Capitalization Ratio Venus Concept Inc.|VERO - Company Long-Term Debt|Company Current Liabilities Venus Concept|Quick Ratio venusconcept.com
- financial results and valuation multiples details:
VERO - Company Net Income|Expected Profit Venus Concept Inc.|VERO - Market Cap to Net Income Ratio|Projected Price to Earnings Venus Concept Corporation|VERO - PEG Multiple|EV/EBITDA Multiple Venus Concept Corp|VERO - Operating income before deduction of amortization|Earnings per share for the last twelve months Venus Concept|VERO - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months venusconcept.com|VERO - Net earnings per share growth this year|Earnings growth forecast for next year Venus Concept Inc.
- sales and revenue indicators:
Fundamental company analysis:VERO (Venus Concept Corp)
Amidst the restructuring of supply chains and the switching of vendors, it is critical to track the forward P/S multiple for Venus Concept Inc. (VERO) to assess revenue sustainability. This indicator compares current market capitalization with projected annual sales, allowing investors to determine the asset's degree of overvaluation and evaluate business liquidity relative to expected cash flows.
Who Venus Concept Inc. competes with
Price-to-Projected Revenue Ratio Dexcom CGM DXCM|Penumbra Corp (PEN) - Market Cap to Future Revenue Ratio|Novanta Inc - Forward P/S Multiple|HAE (Haemonetics Corporation) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED Inc.) - Forward P/S Multiple|Pulse Corp (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward P/S Multiple picardmedical.com (PMI)|Forward P/S Multiple SRDX (surmodics.com)|Forward P/S Multiple Senseonics Holdings, Inc. SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (Sanuwave Health Inc) - Forward Price-to-Revenue Multiple|Projected Price to Revenue Outset Medical OM|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio LENSAR Inc. LNSR|Price-to-Projected Revenue Ratio AVITA Medical Inc. (RCEL)|Profound Medical Corporation (PROF) - Projected Price to Revenue|Baird Medical Investment Holdings - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP Medical EDAP|Apyx Medical Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical ICCM|Pulmonx (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio Corp)|Price-to-Projected Revenue Ratio cytosorbents.com|Forward Price-to-Revenue Multiple Sensus Healthcare, Inc. (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio vicarioussurgical.com RBOT|IINN: Market Cap to Projected Revenue|ICU - Price-to-Projected Revenue Ratio|iridex.com - Price to Expected Revenue Ratio|INBS: Forward P/S Multiple|XAIR (Beyond Air Inc) - Price-to-Projected Revenue Ratio|Price-to-Projected Revenue Ratio Profusa, Inc.|SSKN (strataskinsciences.com) - Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple GCTK (GlucoTrack Inc.)|nanovibronix.com - Market Cap to Projected Revenue|Forward P/S Multiple NUWE (Nuwellis Corp)|Forward Price to Sales AEMD|ASXC - Price-to-Projected Revenue Ratio|Projected Price to Revenue Avinger, Inc (AVGR)|BSGM: Forward P/S Multiple|Cutera (CUTR) - Forward P/S Multiple|KNW (Know Labs) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Inari Medical (NARI)|Price-to-Projected Revenue Ratio nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical)
